Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA6 | P23280 | 5/20 | 0.56 |
| ▸ | CA7 | P43166 | 5/20 | 0.56 |
| ▸ | CA9 | Q16790 | 5/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | CA4 | P22748 | 4/20 | 0.53 |
| ▸ | CA5A | P35218 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CA3 | P07451 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8015113 | 0.94 | CA12 (0.62) | CA12CA6CA7CA9CA14 | |
| SCHEMBL770197 | 0.94 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9437143 | 0.92 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7262297 | 0.92 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL13736532 | 0.84 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18217836 | 0.83 | CA12 (0.40) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18217835 | 0.83 | CA12 (0.40) | CA12CA6CA7CA9CA14 | |
| SCHEMBL11534165 | 0.83 | CA12 (0.48) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9065706 | 0.82 | CA12 (0.48) | CA12CA6CA7CA9CA14 | |
| SCHEMBL394823 | 0.82 | TSHR (0.40) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2887963-B1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX INC (US) | 2017-07-19 | — | — | EP | disclosed |
| US-5604095-A | DNA BINDING PROPERTIES | CANCER THERAPY & RESEARCH CENTER (US) | 1997-02-18 | — | — | US | disclosed |
| US-5561042-A | Diamine platinum naphthalimide complexes as antitumor agents | CANCER THERAPY AND RESEARCH CENTER (US) | 1996-10-01 | — | — | US | disclosed |
| WO-1996003384-A1 | BIS-NAPHTHALIMIDES WITH LINKERS HAVING HETEROATOMS AND USES THEREOF | CTRC RESEARCH FOUNDATION (US) | 1996-02-08 | — | — | WO | disclosed |